Special Statement on Non-Operating Fund Occupation and Other Related Party Transactions of Guangdong Aosheng Pharmaceutical Co., Ltd.
To All Shareholders of Guangdong Aosheng Pharmaceutical Co., Ltd.:
We, Huaxing Certified Public Accountants LLP (Special General Partnership), were entrusted by Guangdong Aosheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Aosheng Pharmaceutical") to audit the consolidated and parent company balance sheets as of December 31, 2025, the consolidated and parent company income statements for the year 2025, the consolidated and parent company cash flow statements, and the consolidated and parent company statements of changes in owners' equity, along with the notes to the financial statements. We issued an unqualified audit report with the report number Huaxing Shen Zi [2026] 25016370015 on April 27, 2026.
In accordance with the requirements of the China Securities Regulatory Commission's "Supervision Guidelines for Listed Companies No. 8 — Supervision Requirements for Listed Company Fund Transactions and External Guarantees" and the format of the summary table for non-operating fund occupation and other related party transactions stipulated in the Shenzhen Stock Exchange's "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 — Business Operations," Aosheng Pharmaceutical has prepared the attached Summary Table of Non-Operating Fund Occupation and Other Related Party Transactions for Guangdong Aosheng Pharmaceutical Co., Ltd. for the Year 2025 (hereinafter referred to as the "Summary Table").